Skip to main content
. 2020 Jun 12;6:24. doi: 10.1038/s41523-020-0165-z

Fig. 1. Case-control study of benign breast biopsy (BBB) samples.

Fig. 1

a Design of the BBCAR study. The sample tissues of subjects who subsequently developed breast cancer (cases), and their matched controls, who have not developed breast cancer to date, were studied b A total of 135 cases, matched to 69 controls, were selected for whole-exome sequencing (WES). Case and control samples are matched by age and histology c. an illustration of the workflow to identify somatic mutations in the tissue samples that lack matched germline DNA. To train a model to distinguish germline variants and somatic mutations, previously consented donors were re-contacted (with IRB approval) and saliva specimens were requested for germline DNA sequencing. Orthogonal SNP array genotyping was further performed with 20 samples to compare and validate the performance of somatic mutation identification.